or
forgot password

10 Years Report of Combined Simultaneous Transpupillary Thermotherapy and ICG-based Photodynamic Therapy for Choroidal Melanoma


Phase 4
18 Years
95 Years
Not Enrolling
Both
Choroidal Melanoma

Thank you

Trial Information

10 Years Report of Combined Simultaneous Transpupillary Thermotherapy and ICG-based Photodynamic Therapy for Choroidal Melanoma


The study was done in a Clinical practice setting. Forty six eyes of 46 patients with small
or medium-sized choroidal melanomas were treated with i-TTT using infrared light delivered
from a diode laser. All patients were evaluated to rule out systemic metastasis and
underwent a complete ophthalmological evaluation including: Slit lamp biomicroscopy, dilated
fundus examination, Fluorescein angiography, Optical coherence tomography and A/B
ultrasonography. Main outcome measures were: Changes in visual acuity, complications
associated with the treatment and local control of the tumor.


Inclusion Criteria:



- Small and medium-sized choroidal melanoma

- Patients older than 18 years old.

- Patients who can read and signed the informed consent.

Exclusion Criteria:

- Patients with ocular inflammation.

- Patients with another active ocular disease.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Retrospective

Principal Investigator

Peter E Liggett, MD

Investigator Role:

Study Director

Investigator Affiliation:

New England Retina Associates

Authority:

United States: Institutional Review Board

Study ID:

NERA-2

NCT ID:

NCT01253759

Start Date:

January 2009

Completion Date:

March 2009

Related Keywords:

  • Choroidal Melanoma
  • Transpupillary thermotherapy
  • Choroidal melanoma
  • ICG-Photodynamic therapy
  • Melanoma

Name

Location
New England Retina Associates Hamden, Connecticut  06518